B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CD38

MOLECULAR TARGET

CD38 molecule

UniProt: P28907NCBI Gene: 9525 compounds

CD38 (CD38 molecule) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CD38

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1quercetagetin3.2625
2robinetin2.7715
3cyanidin2.4010
4kuromanin1.956
5Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691

About CD38 as a Drug Target

CD38 (CD38 molecule) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented CD38 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CD38 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.